Chart calendar ISIS Pharmaceuticals, Inc.
Upcoming events on ISIS Pharmaceuticals, Inc.
Past events on ISIS Pharmaceuticals, Inc.
2024-05-07 11:30 | Q1 2024 Earnings Call |
2024-05-07 07:00 | Q1 2024 Earnings Release |
2024-04-08 15:00 | Needham Healthcare Conference |
2024-04-08 10:00 | Olezarsen Balance Phase 3 Study Results Call |
2024-04-07 10:08 | American College of Cardiology Scientific Meeting |
2024-04-07 08:30 | American College of Cardiology Scientific Meeting |
2024-04-06 | American College of Cardiology Scientific Meeting |
2024-03-20 10:30 | Stifel CNS Day |
2024-03-05 11:10 | TD Cowen Health Care Conference |
2024-02-21 11:30 | Q4 2023 Earnings Call |
2024-02-21 07:00 | Q4 2023 Earnings Release |
2024-01-10 18:00 | JPMorgan Healthcare Conference |
2023-12-03 | BMO Growth & ESG Conference |
2023-11-28 10:00 | Piper Sandler Healthcare Conference |
2023-11-14 10:55 | Stifel Healthcare Conference |
2023-11-07 11:10 | Guggenheim Securities Inflammation & Immunology Conference |
2023-11-02 11:30 | Q3 2023 Earnings Call |
2023-11-02 07:00 | Q3 2023 Earnings Release |
2023-10-04 08:00 | Investor Day |
2023-09-26 11:00 | Olezarsen Phase 3 Topline Study Results Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1 123 1 029 9.18% | 729 712 2.33% | 810 658 23.08% | 587 585 0.33% | 788 634 24.31% | 598 |
EBITDA Million USD | Released Forecast Spread | 378 267 41.94% | -159 -94,0 -68.92% | 130 -194 167.11% | -396 -342 -15.71% | -343 -399 14.09% | -545 |
EBIT Million USD | Released Forecast Spread | 366 286 28.03% | -172 -111 -55.2% | -30,0 -202 85.16% | -411 -362 -13.5% | -353 -464 23.98% | -574 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 347 281 23.62% | -170 -107 -59.01% | -30,0 -207 85.53% | -258 -349 26.08% | -334 -455 26.55% | -571 |
Net income Million USD | Released Forecast Spread | 294 258 13.81% | -451 -77,1 -484.89% | -29,0 -197 85.26% | -270 -354 23.77% | -366 -473 22.64% | -575 |
EPS USD | Released Forecast Spread | 2,08 1,77 17.31% | -3,23 -0,52 -516.11% | -0,20 -1,53 86.92% | -1,90 -2,60 26.96% | -2,56 -3,33 23.13% | -3,80 |
Announcement Date | 26/02/20 | 24/02/21 | 24/02/22 | 22/02/23 | 21/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 142 125 13.43% | 134 143 -6.06% | 160 146 9.84% | 152 160 -5.12% | 131 127 3.24% | 188 142 32.47% | 144 136 5.58% | 325 171 90.17% | 119 136 -12.76% | 145 | 159 | 173 | 139 | 177 |
EBITDA Million USD | Released Forecast Spread | -53,8 -93,0 42.15% | -81,7 -94,0 13.05% | -55,3 -77,0 28.13% | -205 -205 0% | -111 -127 12.29% | -141 -86,0 -63.65% | -3,46 -117 97.03% | -156 | -117 | -104 | -126 | |||
EBIT Million USD | Released Forecast Spread | -57,0 -105 45.46% | -86,0 -91,5 6.01% | -59,0 -105 43.61% | -208 -157 -32.33% | -114 -138 17.55% | -91,0 -124 26.34% | -143 -153 6.77% | -6,00 -127 95.27% | -150 -157 4.17% | -148 | -146 | -142 | -176 | -127 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -64,0 -104 38.71% | -103 -91,6 -12.4% | -47,0 -104 54.97% | -44,0 -131 66.52% | -113 -138 17.82% | -77,0 -123 37.23% | -141 -149 5.28% | -3,00 -123 97.56% | -143 -161 11.32% | -143 | -140 | -142 | -199 | -159 |
Net income Million USD | Released Forecast Spread | -65,0 -101 35.75% | -105 -88,3 -18.96% | -47,0 -103 54.25% | -52,0 -130 60.12% | -124 -141 12.29% | -85,0 -123 31.12% | -147 -147 0.12% | -9,00 -117 92.3% | -143 -157 9.19% | -142 | -140 | -141 | -199 | -159 |
EPS USD | Released Forecast Spread | -0,46 -0,72 35.92% | -0,74 -0,64 -15.94% | -0,33 -0,75 55.98% | -0,37 -0,92 59.82% | -0,87 -0,91 4.67% | -0,60 -0,88 31.71% | -1,03 -1,03 -0.01% | -0,06 -0,86 93.05% | -0,98 -1,07 8.71% | -0,95 | -0,95 | -0,92 | -1,26 | -1,02 |
Announcement Date | 04/05/22 | 09/08/22 | 09/11/22 | 22/02/23 | 03/05/23 | 09/08/23 | 02/11/23 | 21/02/24 | 07/05/24 | - | - | - | - | - |
Past sector events for ISIS Pharmaceuticals, Inc.
2024-05-09 | HUMACYTE, INC.: Q1 2024 Earnings Release |
2024-05-09 | NOVAVAX, INC.: Q1 2024 Earnings Release |
2024-05-09 | TAKARA BIO INC.: Q4 2023 Earnings Release |
2024-05-09 | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
2024-05-09 16:05 | BIOHAVEN LTD.: Q1 2024 Earnings Release |
2024-05-09 16:05 | OMNIAB, INC.: Q1 2024 Earnings Release |
2024-05-09 16:05 | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-09 08:00 | CG ONCOLOGY, INC.: Q1 2024 Earnings Release |
2024-05-09 08:00 | DISC MEDICINE, INC.: Q1 2024 Earnings Release |
2024-05-09 08:00 | VERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |